| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.053 | 0.7 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.044 | 0.7 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |